
    
      Primary endpoint: 30-day post-intervention safety defined as presence of both, radiosurgery
      delivery of the planned dose to the intended target area, and no possibly treatment related
      serious adverse events in the first 30 days after treatment.

      Secondary endpoints: evaluated at 1 year

        -  Changes in ventricular tachycardia episodes and ICD shocks

        -  Changes in antiarrhythmic medication due to treatment effects

        -  Occurrence of possibly treatment related adverse events in the first year after
           treatment (according to CTCAE v5.0)

        -  Changes in patient-reported quality of life (recorded as EQ-5D-5L)

        -  Overall survival

        -  Safety profile
    
  